Internist·Angiologist·Obesity medicine
Prevention built on data, not on impressions.
I am a physician-researcher in Brno, Czech Republic. I head the cardiovascular intensive care unit and the site of the Kardiovize population cohort study at St. Anne's University Hospital, and I teach internal medicine at Masaryk University.
Profile
Robert Prosecký, MD, PhD, MPH is an angiologist, internist and obesity specialist at the 2nd Department of Internal Medicine, St. Anne's University Hospital Brno and the Faculty of Medicine, Masaryk University. He heads the cardiovascular intensive care unit, the clinical nutrition outpatient clinic and the site of the Kardiovize population cohort study, which underpins his research.
He has worked at St. Anne's since 2002. He is board-certified in internal medicine (2010), completed certified training in angiology (2013), earned an MPH in 2017 and defended his PhD at Masaryk University in 2023. His work sits at the intersection of clinical nutrition, cardiometabolic prevention, obesity medicine and vascular medicine — from body-composition phenotyping to prediction modelling.
He teaches medical and nutrition therapy students at Masaryk University and is responsible for the Internal Medicine course for nutrition therapy students. He began teaching nutrition therapy students in 2009 and has been an assistant professor since May 2019. He is the scientific guarantor of the Czech national conference on current therapeutic options in obesity, held for the fifth time on 10 December 2026 in Brno.

Scopus, as of 30 July 2026 · Scopus profile · ORCID 0000-0002-3103-4962 · PubMed
Kardiovize Brno 2030
Kardiovize Brno 2030 is a population-based cohort study run by St. Anne's University Hospital Brno. It invited randomly selected residents of Brno aged 25 to 64, stratified by age and sex. The baseline examination in 2013–2014 reached its target of 1% of the city's population in that age range.
Alongside the classical risk factors the study measures less common ones: the cardio-ankle vascular index (CAVI), carotid intima-media thickness and body fat distribution. Serum, plasma and DNA are stored at −80 °C for further analyses. Follow-up examinations are planned every five years and the study is designed to run until 2030.
I head the study site. The cohort is the data foundation of most of my published work, from body composition and blood pressure to prediction models of insulin resistance.
- Movsisyan NK, et al. Kardiovize Brno 2030, a prospective cardiovascular health study in Central Europe: Methods, baseline findings and future directions. Eur J Prev Cardiol 2018;25:54–64. PMID 28812915
- Kunzova M, et al. Risk factors associated with the consumption of sugar-sweetened beverages among Czech adults: the Kardiovize study. Nutrients 2022;14:5297. PMID 36558456
Clinic, research and teaching
Kardiovize
I head the site of the population cohort study at the 2nd Department of Internal Medicine, St. Anne's University Hospital Brno. The cohort follows cardiovascular risk factors and metabolic syndrome in an ordinary urban population, and it is the data foundation of most of my published work.
Cardiovascular ICU and clinical nutrition clinic
I have worked at St. Anne's University Hospital since 2002. Since 2019 I have headed the cardiovascular intensive care unit at the 2nd Department of Internal Medicine, and since 2024 the clinical nutrition outpatient clinic. My clinical work covers internal medicine, angiology, clinical nutrition and the treatment of obesity.
Prevention programmes
I run prevention programmes focused on cardiometabolic risk. On cohort data I build prediction models of insulin resistance, with the emphasis on interpretability and TRIPOD+AI reporting rather than on maximum AUC.
Faculty of Medicine, Masaryk University
I teach medical students and nutrition therapy students and I am responsible for the Internal Medicine course for nutrition therapy students. I began teaching nutrition therapy students in 2009 and have been an assistant professor since May 2019.
Selected publications
- 2023 Association of anthropometric and body composition parameters with the presence of hypertension in the Central European population: results from KardioVize 2030 study
- 2024 Sarcopenia and adipose tissue evaluation by artificial intelligence predicts the overall survival after TAVI
- 2020 The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure
- 2017 Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women: a 10-year follow-up
- 2017 Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers of atherosclerosis in type 2 diabetes mellitus
Speaking topics
Body composition as a clinical tool: beyond BMI
BMI is a proxy, not a diagnosis. The talk shows what body-composition analysis adds beyond weight and waist circumference, how the metabolically healthy and unhealthy phenotypes of obesity differ, and where risk estimated from BMI parts ways with actual risk. Data from a population cohort.
cardiometabolic phenotyping · cohort data
Cardiometabolic prevention in population data
What a long-followed urban cohort shows about the distribution of risk factors, about differences between the sexes, and about where prevention programmes actually reach the patient and where they miss. The talk is a reading of data, not a review of guidelines.
prevention · epidemiology · Kardiovize
Obesity pharmacotherapy in the internist's office
A practical overview of current obesity pharmacotherapy at the level of drug classes: whom to treat, when to start, what to expect for weight and what for cardiometabolic outcomes. It covers the combination with lifestyle measures and interdisciplinary care.
obesity medicine · drug classes · indications
Prediction models you can defend
How to build a prediction model that survives both peer review and clinical common sense: choice of cohort, interpretability, calibration and TRIPOD+AI reporting, shown on a model of insulin resistance. For physicians and doctoral students; no statistical training required.
machine learning · insulin resistance · TRIPOD+AI
Education and memberships
- 2023
- PhD, Faculty of Medicine, Masaryk University, Brno
- 2019
- Assistant professor of internal medicine, 2nd Department of Internal Medicine, St. Anne's University Hospital Brno and Masaryk University
- 2017
- MPH, Slovak Medical University in Bratislava
- 2013
- Angiology, certified training course, Institute for Postgraduate Medical Education (IPVZ), Prague
- 2010
- Board certification in internal medicine, IPVZ, Prague
- since 2008
- Czech Society of Hypertension
- since 2010
- Czech Society of Cardiology
- since 2013
- Czech Society of Angiology
- since 2017
- Czech Society of Clinical Nutrition and Intensive Metabolic Care
- since 2018
- Czech Society for Atherosclerosis
- since 2019
- Czech Society of Internal Medicine
Contact
Write to me directly. This site collects no personal data: there is no form, no analytics and no cookies.
robert.prosecky@fnusa.cz
robert.prosecky@gmail.com
2nd Department of Internal Medicine, St. Anne's University Hospital Brno
Pekařská 664/53, 602 00 Brno, Czech Republic
A short, medium and long version of my profile in English, ready for conference programmes, is on the Czech home page under the English tab.